Results 201 to 210 of about 1,001,986 (296)
Personalized Nursing Approaches in Monitoring and Managing Hematoma Risks After Percutaneous Renal Biopsy: A Prospective Observational Study. [PDF]
Duan DF +6 more
europepmc +1 more source
ABSTRACT Early diagnosis remains challenging, recurrence rates remain high, and platinum resistance frequently develops in ovarian cancer (OC), collectively representing major barriers to long‐term patient survival. DNA methylation (DNAm), as a relatively stable yet dynamically modifiable epigenetic signature, can capture alterations in tumor states ...
Min Xing +6 more
wiley +1 more source
Transcriptome-wide association study revealed novel causal genes of renal-biopsy proven diabetic nephropathy. [PDF]
Ma Z +8 more
europepmc +1 more source
ABSTRACT Long‐term survival data for patients with locally advanced gastro‐esophageal adenocarcinoma (GEA) treated with neoadjuvant chemoimmunotherapy are lacking. We describe the long‐term disease‐free survival (DFS) and overall survival (OS) outcomes of such patients treated with a novel neoadjuvant chemoimmunotherapy regimen, aDCF (avelumab with ...
Thierry Alcindor +8 more
wiley +1 more source
Correction: Epidemiological study of renal involvement in sarcoidosis in Japan using the Japan Renal Biopsy Registry. [PDF]
Kamata Y +8 more
europepmc +1 more source
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li +29 more
wiley +1 more source
From renal biopsy to genetic diagnosis: EYA1 mutation in branchio-oto-renal syndrome with renal insufficiency. [PDF]
Yang M, Lu M, Feng H, Liu X.
europepmc +1 more source
Multi‐omics–driven precision medicine
Multi‐omics‐driven precision medicine (MODPM) provides a multiscale, continuously learnable framework that integrates genomics, epigenomics, transcriptomics, proteomics, metabolomics, microbiome profiles, and clinical data. Powered by artificial intelligence and foundation models, MODPM enables cross‐modal representation learning, contextual modeling ...
Huibo Li +20 more
wiley +1 more source
Percutaneous renal biopsy adverse event rates: Coaxial or non-coaxial technique. [PDF]
Çakmakçi Sözen M +5 more
europepmc +1 more source

